Fatma Maraiki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fatma Maraiki has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Abdelmoneim Eldali
Biostatistics, Epidemiology, and Scientific Computing Research, King Faisal Specialist Hospital and Research Centre, Riyadh, SAU
1 shared publication - Abdulrahman Alghabban
Department of Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia
1 shared publication - Hazzaa Alzahrani
Adult Hematology, stem cell transplant and cellular therapy section, Cancer Center of Excellence King Faisal Specialist Hospital and Research Center, PO Box 3354, Riyadh, 11471, Saudi Arabia.
1 shared publication - Jihad Aljumaa
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
1 shared publication - Maryam Melaibari
Department of Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
1 shared publication - Mohamed Aseafan
Section of Medical Oncology, Department of Internal Medicine, Security Forces Hospital, Riyadh, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 29 March 2022
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e23624
Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors
Introduction: The relationship between cancers and thromboembolic events is well established. In our study, we aim to determine the burden of thromboembolic events in patients with solid tumors and identify the risk factors related to their development. Materials & Methods: Data on patients with solid tumors and thromboembolism between January 2013 and September 2014 were collected and analyzed. Results: During the study period 174 patients were identified. Of which, 172 (98.9%) had venous thrombus embolism, 137 (79%) were diagnosed with deep vein thromboses, 67 (38.5%) with pulmonary embolism, 84 (48.3%) were symptomatic and 90 (51.7) were incidental at diagnosis. The most common patients and disease characteristics were female sex, high body mass index (BMI), metastatic stage, colorectal and breast primaries, and anti-neoplastic therapy. Conclusion: Our study confirmed the high burden of thromboembolic events in cancer patients and the relevant factors associated with its development.
- 29 March 2022
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e23624
Open AccessThromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors
Introduction: The relationship between cancers and thromboembolic events is well established. In our study, we aim to determine the burden of thromboembolic events in patients with solid tumors and identify the risk factors related to their development. Materials & Methods: Data on patients with solid tumors and thromboembolism between January 2013 and September 2014 were collected and analyzed. Results: During the study period 174 patients were identified. Of which, 172 (98.9%) had venous thrombus embolism, 137 (79%) were diagnosed with deep vein thromboses, 67 (38.5%) with pulmonary embolism, 84 (48.3%) were symptomatic and 90 (51.7) were incidental at diagnosis. The most common patients and disease characteristics were female sex, high body mass index (BMI), metastatic stage, colorectal and breast primaries, and anti-neoplastic therapy. Conclusion: Our study confirmed the high burden of thromboembolic events in cancer patients and the relevant factors associated with its development.